While the number of tau positive microvesicles did not vary between the groups, the mean fluorescent intensity (MFI) of tau-AF488 in tau positive microvesicles was significantly lower in AD patients (Fig. 3). This evidence concerns the gene MAPT and Alzheimer disease.